Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Volatile Organic Compounds | 12 | 2022 | 89 | 3.200 |
Why?
|
| Authorship | 3 | 2022 | 268 | 2.170 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2023 | 761 | 2.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 10 | 2022 | 379 | 1.620 |
Why?
|
| Metabolome | 9 | 2019 | 866 | 1.430 |
Why?
|
| Breath Tests | 6 | 2022 | 288 | 1.270 |
Why?
|
| Klebsiella pneumoniae | 2 | 2018 | 280 | 1.110 |
Why?
|
| Financial Support | 1 | 2021 | 121 | 0.820 |
Why?
|
| Fungi | 3 | 2019 | 320 | 0.820 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 317 | 0.810 |
Why?
|
| Pneumonia | 2 | 2022 | 2094 | 0.770 |
Why?
|
| Natamycin | 1 | 2019 | 5 | 0.770 |
Why?
|
| Blood Cell Count | 1 | 2020 | 420 | 0.730 |
Why?
|
| Fusarium | 1 | 2019 | 55 | 0.730 |
Why?
|
| Enterobacter cloacae | 1 | 2018 | 20 | 0.700 |
Why?
|
| Eye Infections, Fungal | 1 | 2019 | 111 | 0.670 |
Why?
|
| Minority Groups | 2 | 2022 | 1084 | 0.670 |
Why?
|
| Metabolomics | 5 | 2022 | 1379 | 0.670 |
Why?
|
| Financing, Government | 1 | 2022 | 480 | 0.660 |
Why?
|
| Developing Countries | 4 | 2023 | 2720 | 0.640 |
Why?
|
| Food Supply | 1 | 2022 | 461 | 0.630 |
Why?
|
| Wounds, Gunshot | 1 | 2022 | 537 | 0.620 |
Why?
|
| Tuberculosis | 5 | 2022 | 1796 | 0.610 |
Why?
|
| Aspergillus fumigatus | 1 | 2017 | 151 | 0.600 |
Why?
|
| Carboxylic Acids | 1 | 2016 | 106 | 0.600 |
Why?
|
| Aftercare | 1 | 2022 | 705 | 0.590 |
Why?
|
| Emergency Medicine | 2 | 2022 | 1186 | 0.580 |
Why?
|
| Firearms | 1 | 2022 | 552 | 0.560 |
Why?
|
| Lymph Node Excision | 1 | 2021 | 1198 | 0.560 |
Why?
|
| Amino Acids | 1 | 2021 | 1752 | 0.550 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 969 | 0.530 |
Why?
|
| Antifungal Agents | 1 | 2019 | 706 | 0.530 |
Why?
|
| Politics | 1 | 2021 | 756 | 0.530 |
Why?
|
| Information Dissemination | 1 | 2023 | 1098 | 0.520 |
Why?
|
| Hospitals, Pediatric | 2 | 2022 | 1780 | 0.490 |
Why?
|
| Research | 1 | 2021 | 2018 | 0.460 |
Why?
|
| Liberia | 2 | 2022 | 152 | 0.440 |
Why?
|
| Lymphocytes | 1 | 2020 | 2748 | 0.440 |
Why?
|
| Cost of Illness | 1 | 2021 | 1840 | 0.430 |
Why?
|
| Suicide | 1 | 2022 | 1567 | 0.420 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1407 | 0.420 |
Why?
|
| Monocytes | 1 | 2020 | 2661 | 0.400 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 1093 | 0.400 |
Why?
|
| Tanzania | 4 | 2022 | 1171 | 0.390 |
Why?
|
| Blood Platelets | 1 | 2020 | 2474 | 0.370 |
Why?
|
| Patient Discharge | 1 | 2022 | 3010 | 0.360 |
Why?
|
| Streptomyces | 2 | 2019 | 88 | 0.340 |
Why?
|
| Bibliometrics | 2 | 2022 | 334 | 0.330 |
Why?
|
| Patient Readmission | 1 | 2022 | 2962 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 2741 | 0.330 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2022 | 852 | 0.320 |
Why?
|
| Neutrophils | 1 | 2020 | 3850 | 0.320 |
Why?
|
| Bacteria | 1 | 2018 | 2083 | 0.300 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8016 | 0.300 |
Why?
|
| Principal Component Analysis | 3 | 2018 | 970 | 0.290 |
Why?
|
| Pediatrics | 1 | 2021 | 3553 | 0.290 |
Why?
|
| Humans | 44 | 2023 | 715118 | 0.280 |
Why?
|
| Hospitalization | 2 | 2022 | 9718 | 0.270 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2021 | 1912 | 0.270 |
Why?
|
| Income | 3 | 2022 | 1800 | 0.270 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2021 | 1267 | 0.260 |
Why?
|
| Diet | 1 | 2022 | 7583 | 0.260 |
Why?
|
| Child | 11 | 2023 | 74147 | 0.260 |
Why?
|
| Physicians | 1 | 2021 | 4340 | 0.240 |
Why?
|
| United States | 8 | 2023 | 67666 | 0.230 |
Why?
|
| Tuberculosis Vaccines | 1 | 2022 | 50 | 0.230 |
Why?
|
| Area Under Curve | 4 | 2018 | 1693 | 0.220 |
Why?
|
| Calcitonin | 1 | 2023 | 352 | 0.210 |
Why?
|
| Primary Graft Dysfunction | 1 | 2022 | 100 | 0.210 |
Why?
|
| Palatal Muscles | 1 | 2020 | 16 | 0.210 |
Why?
|
| Malawi | 1 | 2021 | 227 | 0.210 |
Why?
|
| Acculturation | 1 | 2021 | 167 | 0.200 |
Why?
|
| Child Mortality | 1 | 2022 | 190 | 0.200 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2022 | 1846 | 0.200 |
Why?
|
| Itraconazole | 1 | 2019 | 38 | 0.190 |
Why?
|
| Homicide | 1 | 2022 | 292 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 23281 | 0.190 |
Why?
|
| Cystic Fibrosis | 2 | 2018 | 1152 | 0.190 |
Why?
|
| Eustachian Tube | 1 | 2020 | 98 | 0.190 |
Why?
|
| Granulocytes | 1 | 2021 | 557 | 0.190 |
Why?
|
| Ciprofloxacin | 1 | 2021 | 313 | 0.180 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 689 | 0.180 |
Why?
|
| Ear Diseases | 1 | 2020 | 177 | 0.180 |
Why?
|
| ROC Curve | 4 | 2018 | 3526 | 0.170 |
Why?
|
| Infant | 5 | 2022 | 34497 | 0.170 |
Why?
|
| Exhalation | 1 | 2018 | 173 | 0.160 |
Why?
|
| Genes, Bacterial | 2 | 2019 | 1145 | 0.160 |
Why?
|
| Bacterial Typing Techniques | 1 | 2018 | 285 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2018 | 295 | 0.160 |
Why?
|
| Lung Injury | 1 | 2022 | 402 | 0.160 |
Why?
|
| Oral Surgical Procedures | 1 | 2019 | 162 | 0.160 |
Why?
|
| Carbapenems | 1 | 2018 | 129 | 0.160 |
Why?
|
| Cresols | 1 | 2016 | 31 | 0.160 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2018 | 156 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 1529 | 0.160 |
Why?
|
| Disasters | 1 | 2022 | 484 | 0.150 |
Why?
|
| Microbial Interactions | 1 | 2017 | 80 | 0.150 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 203 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 484 | 0.150 |
Why?
|
| Mycobacterium | 1 | 2017 | 257 | 0.140 |
Why?
|
| beta-Lactamases | 1 | 2018 | 369 | 0.140 |
Why?
|
| Staphylococcus aureus | 2 | 2021 | 1398 | 0.140 |
Why?
|
| Health Education | 1 | 2022 | 1060 | 0.140 |
Why?
|
| Infant, Newborn | 4 | 2023 | 24645 | 0.140 |
Why?
|
| Suture Techniques | 1 | 2020 | 796 | 0.140 |
Why?
|
| Publishing | 1 | 2022 | 800 | 0.140 |
Why?
|
| North America | 1 | 2018 | 1196 | 0.140 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 4005 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2019 | 1877 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2022 | 1548 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 617 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2971 | 0.120 |
Why?
|
| Lung Transplantation | 1 | 2022 | 1157 | 0.120 |
Why?
|
| Plasmids | 1 | 2018 | 2496 | 0.110 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 774 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 816 | 0.110 |
Why?
|
| Europe | 1 | 2018 | 3345 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2022 | 1784 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1023 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 3707 | 0.100 |
Why?
|
| Tuberculin Test | 2 | 2022 | 213 | 0.100 |
Why?
|
| Solid Phase Microextraction | 2 | 2022 | 5 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1334 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2022 | 51182 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 969 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2019 | 3017 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1724 | 0.100 |
Why?
|
| Psychiatry | 1 | 2022 | 1615 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3433 | 0.090 |
Why?
|
| Adolescent | 7 | 2022 | 85001 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 2422 | 0.090 |
Why?
|
| Students, Medical | 1 | 2021 | 1764 | 0.090 |
Why?
|
| Male | 12 | 2022 | 351080 | 0.090 |
Why?
|
| Female | 13 | 2022 | 377328 | 0.090 |
Why?
|
| Length of Stay | 1 | 2022 | 6278 | 0.080 |
Why?
|
| Discriminant Analysis | 2 | 2018 | 241 | 0.080 |
Why?
|
| Least-Squares Analysis | 2 | 2018 | 387 | 0.080 |
Why?
|
| Pain | 1 | 2022 | 4662 | 0.080 |
Why?
|
| Registries | 1 | 2023 | 8090 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2022 | 41183 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 16011 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2018 | 4339 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2022 | 72253 | 0.070 |
Why?
|
| Genotype | 1 | 2018 | 12921 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7045 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7480 | 0.050 |
Why?
|
| Incidence | 1 | 2020 | 20596 | 0.050 |
Why?
|
| Corynebacterium | 1 | 2021 | 48 | 0.050 |
Why?
|
| Arginase | 1 | 2021 | 79 | 0.050 |
Why?
|
| Adult | 8 | 2022 | 212128 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 127 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 198 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2022 | 23510 | 0.050 |
Why?
|
| Stillbirth | 1 | 2022 | 307 | 0.050 |
Why?
|
| Volatilization | 1 | 2019 | 81 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2019 | 156 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 141 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20397 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2021 | 501 | 0.040 |
Why?
|
| Serotyping | 1 | 2018 | 378 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2019 | 307 | 0.040 |
Why?
|
| Laryngoscopes | 1 | 2019 | 145 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2020 | 358 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 953 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 23975 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2022 | 8043 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 123 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2022 | 845 | 0.040 |
Why?
|
| Cadaver | 1 | 2020 | 1375 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2033 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2021 | 983 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 70705 | 0.030 |
Why?
|
| Culture Media | 1 | 2017 | 953 | 0.030 |
Why?
|
| Middle Aged | 4 | 2022 | 214868 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2018 | 453 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2019 | 716 | 0.030 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 549 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56155 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2019 | 1158 | 0.030 |
Why?
|
| Probability | 1 | 2018 | 2480 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2021 | 2529 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 2621 | 0.030 |
Why?
|
| Cause of Death | 1 | 2022 | 3587 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2252 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6538 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4916 | 0.020 |
Why?
|
| Poverty | 1 | 2022 | 2577 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6289 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3933 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2794 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4010 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 14869 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 4849 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10380 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21789 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 16680 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14877 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16373 | 0.010 |
Why?
|
| Mice | 2 | 2019 | 80997 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 27180 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22941 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 39804 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 170733 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58503 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29441 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 162672 | 0.010 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_